Lilly: Hims & Hers shares rise as company adds new weight-loss medications to platform
Hims & Hers Health shares closed up 5% on Tuesday after the company announced patients can access Eli Lilly’s weight loss medication Zepbound and diabetes drug Mounjaro, as well as the generic injection liraglutide, through its platform
Read full article »
Lilly is a Massachusetts-based pharmaceutical company that develops, produces and markets pharmaceutical products for healthcare professionals, patients and consumers.
Read more